Cargando…

Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration

BACKGROUND: Convalescent plasma obtained from individuals who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contains neutralizing antibodies to the virus and has been frequently used as a treatment in hospitalized patients with severe COVID-19. METHODS: We conducte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cain, Wesley V, Sill, Anne M, Solipuram, Vinod, Weiss, John J, Miller, Carole B, Jelsma, Peter F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509285/ https://www.ncbi.nlm.nih.gov/pubmed/36164495 http://dx.doi.org/10.1155/2022/7992927

Ejemplares similares

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

The Assessment of Convalescent Plasma Efficacy against COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2020)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID‐19
por: Liao, Mingfeng, et al.
Publicado: (2021)

Convalescent plasma appears efficacious and safe in COVID-19
por: Khulood, Daulat, et al.
Publicado: (2020)

Convalescent plasma to deliver therapeutic antibodies against COVID-19
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
por: Joyner, Michael J., et al.
Publicado: (2021)

Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19: clinical experience and efficacy
por: Pei, Shiyao, et al.
Publicado: (2021)

Efficacy of convalescent plasma therapy in severe COVID-19 patients
por: Akay Cizmecioglu, Hilal, et al.
Publicado: (2021)

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions
por: Bonetti, Tatiana Carvalho de Souza, et al.
Publicado: (2021)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
por: Devos, Timothy, et al.
Publicado: (2022)

Efficacy of convalescent plasma for the treatment of severe influenza
por: Xu, Zhiheng, et al.
Publicado: (2020)

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy
por: Casadevall, Arturo, et al.
Publicado: (2020)

Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy
por: Kumar, Saurabh, et al.
Publicado: (2021)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
por: Tirnea, Livius, et al.
Publicado: (2021)

Efficacy of convalescent plasma according to blood groups in COVID-19 patients
por: HACIBEKİROĞLU, Tuba, et al.
Publicado: (2021)

Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
por: Franchini, Massimo, et al.
Publicado: (2021)

The art of the possible in approaching efficacy trials for COVID19 convalescent plasma
por: Focosi, Daniele, et al.
Publicado: (2021)

Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
por: Morgenlander, William, et al.
Publicado: (2020)

Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
por: Raadsen, Matthijs P., et al.
Publicado: (2021)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations
por: Park, Han-Sol, et al.
Publicado: (2023)

Neutralizing antibodies in convalescent patients
por: Uhl, Lion F. K., et al.
Publicado: (2020)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Convalescent plasma for administration of passive antibodies against viral agents
por: Di Minno, Giovanni, et al.
Publicado: (2020)

Early administration of COVID‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy
por: Belov, Artur, et al.
Publicado: (2022)

Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial
por: Franchini, Massimo, et al.
Publicado: (2021)

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
por: Uzun, Günalp, et al.
Publicado: (2023)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency
por: Lang-Meli, Julia, et al.
Publicado: (2021)

Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
por: Jazbec, Katerina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_topisu0fhdfg4fg5d8n65eg5j6